Biosolution Co.Ltd (086820) — Financial Flexibility Index
Biosolution Co.Ltd (086820) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of ₩39.56 Million (operating CF ₩17.41 Million minus capex ₩22.15 Million) represents 0% of total liabilities (₩36.25 Billion). Check Biosolution Co.Ltd (086820) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biosolution Co.Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Biosolution Co.Ltd across 10 annual periods. For the full cash flow conversion analysis, see 086820 cash flow metrics.
Annual Financial Flexibility Index for Biosolution Co.Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Biosolution Co.Ltd. Explore Biosolution Co.Ltd (086820) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.03x | ₩-1.06 Billion | ₩-2.29 Billion | ₩36.21 Billion | ▼ -144.2% |
| 2023 | 0.07x | ₩3.32 Billion | ₩2.16 Billion | ₩50.22 Billion | ▲ +1069.9% |
| 2022 | 0.01x | ₩270.90 Million | ₩-3.81 Billion | ₩47.96 Billion | ▼ -62.6% |
| 2021 | 0.02x | ₩746.44 Million | ₩83.29 Million | ₩49.39 Billion | ▲ +116.0% |
| 2020 | -0.09x | ₩-295.41 Million | ₩-1.69 Billion | ₩3.13 Billion | ▲ +18.1% |
| 2019 | -0.12x | ₩-427.10 Million | ₩-2.61 Billion | ₩3.71 Billion | ▼ -125.2% |
| 2018 | 0.46x | ₩1.73 Billion | ₩1.03 Billion | ₩3.80 Billion | ▲ +1135.9% |
| 2017 | 0.04x | ₩109.24 Million | ₩-78.53 Million | ₩2.96 Billion | ▲ +110.7% |
| 2016 | -0.34x | ₩-927.01 Million | ₩-2.07 Billion | ₩2.70 Billion | ▲ +44.2% |
| 2015 | -0.62x | ₩-1.47 Billion | ₩-2.02 Billion | ₩2.40 Billion | — |